BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 15862964)

  • 1. Role of steroid hormones and prolactin in canine mammary cancer.
    Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes C; Illera JC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):181-7. PubMed ID: 15862964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and Tissue Steroid Hormone Levels in Canine Mammary Tumours: Clinical and Prognostic Implications.
    Queiroga FL; Pérez-Alenza D; González-Gil A; Silván G; Peña L; Illera JC
    Reprod Domest Anim; 2015 Oct; 50(5):858-65. PubMed ID: 26332137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroids and receptors in canine mammary cancer.
    Illera JC; Pérez-Alenza MD; Nieto A; Jiménez MA; Silvan G; Dunner S; Peña L
    Steroids; 2006 Jul; 71(7):541-8. PubMed ID: 16631217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between GH/IGF-I axis and steroid hormones (progesterone, 17beta-estradiol) in canine mammary tumours.
    Queiroga FL; Pérez-Alenza MD; Silvan G; Peña L; Lopes CS; Illera JC
    J Steroid Biochem Mol Biol; 2008 May; 110(1-2):76-82. PubMed ID: 18367392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive correlation of steroid hormones and EGF in canine mammary cancer.
    Queiroga FL; Pérez-Alenza D; Silvan G; Peña L; Illera JC
    J Steroid Biochem Mol Biol; 2009 May; 115(1-2):9-13. PubMed ID: 19429455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin binding in benign and malignant mammary tissue of female dogs.
    Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
    Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine control of canine mammary neoplasms: serum reproductive hormone levels and tissue expression of steroid hormone, prolactin and growth hormone receptors.
    Spoerri M; Guscetti F; Hartnack S; Boos A; Oei C; Balogh O; Nowaczyk RM; Michel E; Reichler IM; Kowalewski MP
    BMC Vet Res; 2015 Sep; 11():235. PubMed ID: 26370564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormonal background of canine and feline mammary tumours.
    Rutteman GR; Misdorp W
    J Reprod Fertil Suppl; 1993; 47():483-7. PubMed ID: 8229967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone profile of canine inflammatory mammary carcinoma: a preliminary study.
    Peña L; Silván G; Pérez-Alenza MD; Nieto A; Illera JC
    J Steroid Biochem Mol Biol; 2003 Feb; 84(2-3):211-6. PubMed ID: 12711005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormones and mammary tumour disease in the female dog: an update.
    Rutteman GR
    In Vivo; 1990; 4(1):33-40. PubMed ID: 2103839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
    Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
    J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and significance of PTEN in canine mammary gland tumours.
    Qiu C; Lin D; Wang J; Wang L
    Res Vet Sci; 2008 Oct; 85(2):383-8. PubMed ID: 18082231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
    Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
    Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior pituitary function in female dogs with mammary tumors: II. Prolactin.
    Rutteman GR; Bevers MM; Misdorp W; Van den Brom WE
    Anticancer Res; 1989; 9(1):241-5. PubMed ID: 2495756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of P-glycoprotein (clone C494) in canine mammary gland tumours.
    Petterino C; Rossetti E; Bertoncello D; Martini M; Zappulli V; Bargelloni L; Castagnaro M
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):174-8. PubMed ID: 16629950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hormones and mammary tumors in the bitch: a review].
    Rutteman GR
    Tijdschr Diergeneeskd; 1992 Feb; 117(3):71-7, 81. PubMed ID: 1736405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic implications of serum and tissue prolactin levels in canine mammary tumours.
    Queiroga FL; Pérez-Alenza MD; González Gil A; Silvan G; Peña L; Illera JC
    Vet Rec; 2014 Oct; 175(16):403. PubMed ID: 25096592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum neopterin, sialic acid and nitric oxide levels in dogs with malignant mammary tumours.
    Tascene N; Kısmalı G; Vural S; Karagul H; Sel T
    Vet Comp Oncol; 2012 Jun; 10(2):155-9. PubMed ID: 22235796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of VEGF-C expression in canine mammary tumours.
    Qiu C; Lin DD; Wang HH; Qiao CH; Wang J; Zhang T
    Aust Vet J; 2008 Jul; 86(7):279-82. PubMed ID: 18616481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.